Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

A single nucleotide polymorphism in codon F31I and V57I of the AURKA gene in invasive ductal breast carcinoma in Middle East.

Golmohammadi R, Namazi MJ, Going JJ, Derakhshan MH.

Medicine (Baltimore). 2017 Sep;96(37):e7933. doi: 10.1097/MD.0000000000007933.

2.

ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation.

Rostami K, Marsh MN, Johnson MW, Mohaghegh H, Heal C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassotti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan MH, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going JJ, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder CJ, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali MR, Srivastava A.

Gut. 2017 Dec;66(12):2080-2086. doi: 10.1136/gutjnl-2017-314297. Epub 2017 Sep 11.

3.

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.

Dreyer SB, Powell AG, McSorley ST, Waterston A, Going JJ, Edwards J, McMillan DC, Horgan PG.

Ann Surg Oncol. 2017 May;24(5):1295-1303. doi: 10.1245/s10434-016-5684-3. Epub 2016 Nov 21.

4.

The gastric acid pocket is attenuated in H. pylori infected subjects.

Mitchell DR, Derakhshan MH, Wirz AA, Orange C, Ballantyne SA, Going JJ, McColl KEL.

Gut. 2017 Sep;66(9):1555-1562. doi: 10.1136/gutjnl-2016-312638. Epub 2016 Sep 23.

PMID:
27663505
5.

Response to Crocetti et al.

Derakhshan MH, Arnold M, Brewster DH, Going JJ, Mitchell DR, Forman D, McColl KE.

Am J Gastroenterol. 2016 Aug;111(8):1202-3. doi: 10.1038/ajg.2016.228. No abstract available.

PMID:
27481422
6.

The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

van Wyk HC, Park JH, Edwards J, Horgan PG, McMillan DC, Going JJ.

Br J Cancer. 2016 Jul 12;115(2):156-63. doi: 10.1038/bjc.2016.173. Epub 2016 Jun 14.

7.

Hiatus hernia in healthy volunteers is associated with intrasphincteric reflux and cardiac mucosal lengthening without traditional reflux.

Robertson EV, Derakhshan MH, Wirz AA, Mitchell DR, Going JJ, Kelman AW, Ballantyne SA, McColl KEL.

Gut. 2017 Jul;66(7):1208-1215. doi: 10.1136/gutjnl-2016-311553. Epub 2016 Apr 25.

PMID:
27196581
8.

Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects.

Derakhshan MH, Arnold M, Brewster DH, Going JJ, Mitchell DR, Forman D, McColl KE.

Am J Gastroenterol. 2016 Feb;111(2):228-39. doi: 10.1038/ajg.2015.405. Epub 2016 Jan 12.

PMID:
26753891
9.

An unexpected mucosal metaplasia at the gastric cardia in longstanding pernicious anemia.

Derakhshan MH, Crumley A, Forshaw M, Mitchell DR, Going JJ.

Am J Gastroenterol. 2015 Oct;110(10):1505-6. doi: 10.1038/ajg.2015.288. No abstract available.

PMID:
26465909
10.

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.

Gujam FJ, McMillan DC, Mohammed ZM, Edwards J, Going JJ.

Br J Cancer. 2015 Sep 29;113(7):1066-74. doi: 10.1038/bjc.2015.287. Epub 2015 Aug 11.

11.

Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus.

Moyes LH, Oien KA, Foulis AK, Fullarton GM, Going JJ.

Gut. 2016 Feb;65(2):360-1. doi: 10.1136/gutjnl-2015-309978. Epub 2015 Jun 17. No abstract available.

12.

Microscopic enteritis: Bucharest consensus.

Rostami K, Aldulaimi D, Holmes G, Johnson MW, Robert M, Srivastava A, Fléjou JF, Sanders DS, Volta U, Derakhshan MH, Going JJ, Becheanu G, Catassi C, Danciu M, Materacki L, Ghafarzadegan K, Ishaq S, Rostami-Nejad M, Peña AS, Bassotti G, Marsh MN, Villanacci V.

World J Gastroenterol. 2015 Mar 7;21(9):2593-604. doi: 10.3748/wjg.v21.i9.2593. Review.

13.

In healthy volunteers, immunohistochemistry supports squamous to columnar metaplasia as mechanism of expansion of cardia, aggravated by central obesity.

Derakhshan MH, Robertson EV, Yeh Lee Y, Harvey T, Ferrier RK, Wirz AA, Orange C, Ballantyne SA, Hanvey SL, Going JJ, McColl KE.

Gut. 2015 Nov;64(11):1705-14. doi: 10.1136/gutjnl-2014-308914. Epub 2015 Mar 9.

PMID:
25753030
14.

Aneusomy detected by fluorescence in-situ hybridization has high positive predictive value for Barrett's dysplasia.

Allan EA, Miller R, Going JJ.

Histopathology. 2015 Oct;67(4):451-6. doi: 10.1111/his.12679. Epub 2015 Apr 27.

PMID:
25735914
15.

Gastric neo-adenocarcinoma arising in a gastric tube after Ivor Lewis oesophagectomy for oesophageal adenocarcinoma.

Hanif F, Kerr J, Going JJ, Fullarton G.

Scott Med J. 2015 May;60(2):e17-20. doi: 10.1177/0036933015570520. Epub 2015 Feb 3.

PMID:
25652293
16.

Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.

Gujam FJ, Going JJ, Mohammed ZM, Orange C, Edwards J, McMillan DC.

BMC Cancer. 2014 Sep 18;14:676. doi: 10.1186/1471-2407-14-676.

17.

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC.

Br J Cancer. 2014 Jul 8;111(1):157-65. doi: 10.1038/bjc.2014.279. Epub 2014 May 29.

18.

The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, McMillan DC, Edwards J, Mallon E, Doughty JC, Orange C, Going JJ.

BMC Clin Pathol. 2013 Nov 25;13(1):31. doi: 10.1186/1472-6890-13-31.

19.

Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.

Sadjadi A, Yazdanbod A, Lee YY, Boreiri M, Samadi F, Alizadeh BZ, Islami F, Fyfe V, Babaei M, Namazi MJ, Going JJ, Sotoudeh M, de Bock GH, Malekzadeh R, Derakhshan MH.

PLoS One. 2013 Sep 30;8(9):e74440. doi: 10.1371/journal.pone.0074440. eCollection 2013.

20.

The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.

Gujam FJ, Going JJ, Edwards J, Mohammed ZM, McMillan DC.

Crit Rev Oncol Hematol. 2014 Feb;89(2):231-41. doi: 10.1016/j.critrevonc.2013.08.014. Epub 2013 Sep 12. Review.

PMID:
24075309
21.

The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up.

Powell AG, Ferguson J, Al-Mulla F, Orange C, McMillan DC, Horgan PG, Edwards J, Going JJ.

J Cancer Res Clin Oncol. 2013 Dec;139(12):2013-20. doi: 10.1007/s00432-013-1521-2. Epub 2013 Sep 26.

PMID:
24072233
22.

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, Going JJ, Edwards J, Elsberger B, McMillan DC.

Br J Cancer. 2013 Sep 17;109(6):1676-84. doi: 10.1038/bjc.2013.493. Epub 2013 Aug 27.

23.

Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa.

Robertson EV, Derakhshan MH, Wirz AA, Lee YY, Seenan JP, Ballantyne SA, Hanvey SL, Kelman AW, Going JJ, McColl KE.

Gastroenterology. 2013 Oct;145(4):730-9. doi: 10.1053/j.gastro.2013.06.038. Epub 2013 Jun 22.

PMID:
23796455
24.

Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer.

Mohammed ZM, Orange C, McMillan DC, Mallon E, Doughty JC, Edwards J, Going JJ.

Hum Pathol. 2013 Aug;44(8):1688-95. doi: 10.1016/j.humpath.2012.11.023. Epub 2013 Apr 8.

PMID:
23574778
25.

Specific histological abnormalities are more likely in biopsies of endoscopically normal large bowel after the age of 60 years.

O'Mahony OH, Burgoyne M, Going JJ.

Histopathology. 2012 Dec;61(6):1209-13. doi: 10.1111/j.1365-2559.2012.04317.x. Epub 2012 Aug 9.

PMID:
22882180
26.

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC.

Br J Cancer. 2012 Aug 21;107(5):864-73. doi: 10.1038/bjc.2012.347. Epub 2012 Aug 9.

27.

Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer.

Mohammed ZM, Going JJ, McMillan DC, Orange C, Mallon E, Doughty JC, Edwards J.

Histopathology. 2012 Oct;61(4):675-84. doi: 10.1111/j.1365-2559.2012.04280.x.

PMID:
22747525
28.

Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus.

Moyes LH, McEwan H, Radulescu S, Pawlikowski J, Lamm CG, Nixon C, Sansom OJ, Going JJ, Fullarton GM, Adams PD.

J Pathol. 2012 Sep;228(1):99-112. doi: 10.1002/path.4058. Epub 2012 Jul 18.

PMID:
22653845
29.

The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer.

Mohammed ZM, Going JJ, Edwards J, McMillan DC.

Cancer Treat Rev. 2012 Dec;38(8):943-55. doi: 10.1016/j.ctrv.2012.04.011. Epub 2012 May 30. Review.

PMID:
22651904
30.

The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.

Richards CH, Flegg KM, Roxburgh CS, Going JJ, Mohammed Z, Horgan PG, McMillan DC.

Br J Cancer. 2012 Jun 5;106(12):2010-5. doi: 10.1038/bjc.2012.211. Epub 2012 May 17.

31.

Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis.

Mohammed ZM, Edwards J, Orange C, Mallon E, Doughty JC, McMillan DC, Going JJ.

Histopathology. 2012 Aug;61(2):283-92. doi: 10.1111/j.1365-2559.2012.04244.x. Epub 2012 May 9.

PMID:
22571413
32.

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA.

Gastroenterology. 2012 Aug;143(2):336-46. doi: 10.1053/j.gastro.2012.04.032. Epub 2012 Apr 24.

33.

The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.

Powell AG, Wallace R, McKee RF, Anderson JH, Going JJ, Edwards J, Horgan PG.

Colorectal Dis. 2012 Dec;14(12):1493-9. doi: 10.1111/j.1463-1318.2012.03048.x.

PMID:
22507826
34.

Subgross breast pathology in the twenty-first century.

Smith WA, Going JJ.

Virchows Arch. 2012 May;460(5):489-95. doi: 10.1007/s00428-012-1226-y. Epub 2012 Mar 30.

PMID:
22460856
35.

Prospective study of the role of inflammation in renal cancer.

Qayyum T, McArdle PA, Lamb GW, Going JJ, Orange C, Seywright M, Horgan PG, Oades G, Aitchison MA, Edwards J.

Urol Int. 2012;88(3):277-81. doi: 10.1159/000334971. Epub 2012 Feb 23.

PMID:
22377628
36.

Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.

Mohammed ZM, McMillan DC, Elsberger B, Going JJ, Orange C, Mallon E, Doughty JC, Edwards J.

Br J Cancer. 2012 Jan 17;106(2):383-8. doi: 10.1038/bjc.2011.569. Epub 2012 Jan 3.

37.

The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma.

Dutta S, Going JJ, Crumley AB, Mohammed Z, Orange C, Edwards J, Fullarton GM, Horgan PG, McMillan DC.

Br J Cancer. 2012 Feb 14;106(4):702-10. doi: 10.1038/bjc.2011.610. Epub 2012 Jan 12.

38.

Is the presence or absence of tumour necrosis a significant predictor of survival in renal cell cancer?

Qayyum T, McArdle PA, Going JJ, Orange C, Seywright M, Aitchison MA, Edwards J.

Urol Int. 2012;88(1):79-83. doi: 10.1159/000332430. Epub 2011 Oct 27.

PMID:
22041976
39.

Barrett's esophagus: histology and immunohistology.

Barr H, Upton MP, Orlando RC, Armstrong D, Vieth M, Neumann H, Langner C, Wiley EL, Das KM, Pickett-Blakely OE, Bajpai M, Amenta PS, Bennett A, Going JJ, Younes M, Wang HH, Taddei A, Freschi G, Ringressi MN, Degli'innocenti DR, Castiglione F, Bechi P.

Ann N Y Acad Sci. 2011 Sep;1232:76-92. doi: 10.1111/j.1749-6632.2011.06046.x.

PMID:
21950808
40.

Observer prediction of HER2 amplification in HercepTest 2+ breast cancers as a potential audit instrument.

Going JJ.

Histopathology. 2011 Aug;59(2):333-5. doi: 10.1111/j.1365-2559.2011.03879.x.

PMID:
21884213
41.

Still waiting for predictive biomarkers in Barrett's oesophagus.

Moyes LH, Going JJ.

J Clin Pathol. 2011 Sep;64(9):742-50. doi: 10.1136/jclinpath-2011-200084. Epub 2011 May 23. Review.

PMID:
21606229
42.

Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer.

Crumley AB, Going JJ, Hilmy M, Dutta S, Tannahill C, McKernan M, Edwards J, Stuart RC, McMillan DC.

Ann Surg Oncol. 2011 Sep;18(9):2604-12. doi: 10.1245/s10434-011-1658-7. Epub 2011 Mar 16.

PMID:
21409484
43.

Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series.

Crumley AB, Going JJ, McEwan K, McKernan M, Abela JE, Shearer CJ, Stanley AJ, Stuart RC.

Surg Endosc. 2011 Feb;25(2):543-8. doi: 10.1007/s00464-010-1213-9. Epub 2010 Jul 10.

PMID:
20623237
44.

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R.

Ann Surg. 2010 Jun;251(6):1003-10. doi: 10.1097/SLA.0b013e3181d77369.

PMID:
20485150
45.

Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia.

McColl KE, Going JJ.

Gut. 2010 Mar;59(3):282-4. doi: 10.1136/gut.2009.186825. No abstract available.

PMID:
20207629
46.

Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system.

Crumley AB, Stuart RC, McKernan M, Going JJ, Shearer CJ, McMillan DC.

J Gastrointest Surg. 2010 May;14(5):781-7. doi: 10.1007/s11605-010-1162-6. Epub 2010 Feb 11.

PMID:
20148314
47.

Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all.

Gaya DR, Stuart RC, Going JJ, Stanley AJ.

Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1249-51. doi: 10.1097/MEG.0b013e328303df31. No abstract available.

PMID:
18989144
48.

Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.

Abela JE, Going JJ, Mackenzie JF, McKernan M, O'Mahoney S, Stuart RC.

Am J Gastroenterol. 2008 Apr;103(4):850-5. doi: 10.1111/j.1572-0241.2007.01746.x. Epub 2008 Mar 26.

PMID:
18371135
49.

Modified classification for adenocarcinoma of the gastro-oesophageal junction.

Shearer CJ, Going JJ, Neilson LJ, Stuart RC.

ANZ J Surg. 2007 Jul;77(7):544-9.

PMID:
17610690
50.

Aberrant expression of TopBP1 in breast cancer.

Going JJ, Nixon C, Dornan ES, Boner W, Donaldson MM, Morgan IM.

Histopathology. 2007 Mar;50(4):418-24.

PMID:
17448016

Supplemental Content

Loading ...
Support Center